CD8A and relapsing-remitting multiple sclerosis: A few studies investigated the frequency of circulating CD8+ CD161high T cells in MS subjects, with contradictory results in relapsing-remitting MS or pooled cohorts of MS patients with different disease courses (9, 23–25).